Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers

Thrombosis and Haemostasis

Volumn 85, Issue 6, 2001, Pages 999-1003

  Morange, P E ^a   Renucci, J F ^a   Charles, M A ^a   Aillaud, M F ^a   Giraud, F ^a   Grimaux, M ^a   Juhan Vague, I ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Cardiovascular risk factors; Endothelial cell markers; Free total TFPI

Indexed keywords

CELL MARKER; FIBRINOGEN; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGE; ANTICOAGULATION; ARTICLE; BLOOD LEVEL; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORRELATION FUNCTION; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HIGH RISK POPULATION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; PLASMA; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RISK FACTOR; SEX DIFFERENCE; VARIANCE;

EID: 0034966562     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615954     Document Type: Article

References (21)

1. Regulation of coagulation by a multivalent Kunitz-type inhibitor
2. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: Evidence that endothelium is the principal site of its synthesis
3. Tissue factor pathway inhibitor (TFPI) - An update
4. Measurement of the free form of TFPI antigen in hyperlipidemia - Relationship between free and endothelial cell-associated forms of TFPI
5. Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II
6. Development of a method to separate lipoprotein-bound and lipoprotein-depleted tissue factor pathway inhibitor. Measurement of free tissue factor pathway inhibitor activity
7. Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients
8. Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in vitro
9. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity
10. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: Effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions
11. Factor VII and extrinsic pathway inhibitor in acute coronary disease
12. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients
13. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina
14. Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: A family study with part of the Stanislas Cohort
15. Difference in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls
16. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria
17. Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy
18. Mechanism on disorders of coagulation and fibrinolysis in diabetes
19. Increased tissue factor pathway inhibitor (TFPI) and coagulation in patients with insulin-dependent diabetes mellitus
20. Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men
21. Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: Relationship to elevated TPA antigen in patients with high PAI-1 activity levels